Health
UK Launches 3rd Booster Dose Trial of 7 COVID-19 Vaccines Including Oxford-AstraZeneca, Pfizer-BioNTech And – LatestLY
In a first, the UK has launched a new clinical trial that will assess the efficacy of a third ‘booster’ dose of seven different COVID-19 vaccines on patients’ immune…
London, May 21: In a first, the UK has launched a new clinical trial that will assess the efficacy of a third ‘booster’ dose of seven different COVID-19 vaccines on patients’ immune responses, the media reported.
The trial will assess COVID-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac. COVID-19 Cases Will Rise Despite Vaccination: UK Scientists
The trial, named Cov-Boost, aims to begin in June and recruit 3,000 people of all ages who had their…
-
Noosa News23 hours agoThe small patch of paddock emitting 10,000 cars’ worth of methane
-
Business23 hours agoDown more than 20% this year, does Macquarie rate Boss Energy shares a buy?
-
Business24 hours agoGuess which ASX 200 stock is rocketing on big US news
-
Noosa News24 hours agoBrisbane City Council to tap private sector for Riverstage upgrade